Clinical trial
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone…
NCT00499707 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00499707 |
|---|---|
| Title | Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects |
| Official title | A Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Fixed Dose Rosiglitazone/Metformin Combination Therapy Compared to Both Rosiglitazone and Metformin Monotherapies in Drug Naive Type 2 Diabetes Mellitus Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | rosiglitazone maleate/metformin hydrochloride |
| Enrollment | 453 |
| Start date | Oct 8, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 16, 2004 |
| First posted | Jul 11, 2007 |
| Last update posted | Mar 21, 2018 |
| Countries | Australia, Brazil, Canada, Mexico, New Zealand, South Korea, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: